Cargando…
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594077/ https://www.ncbi.nlm.nih.gov/pubmed/34801920 http://dx.doi.org/10.1016/j.thromres.2021.11.008 |
| _version_ | 1784599893111734272 |
|---|---|
| author | Zuin, Marco Cervellati, Carlo Rigatelli, Gianluca Zuliani, Giovanni Roncon, Loris |
| author_facet | Zuin, Marco Cervellati, Carlo Rigatelli, Gianluca Zuliani, Giovanni Roncon, Loris |
| author_sort | Zuin, Marco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8594077 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85940772021-11-16 Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? Zuin, Marco Cervellati, Carlo Rigatelli, Gianluca Zuliani, Giovanni Roncon, Loris Thromb Res Letter to the Editors-in-Chief Elsevier Ltd. 2021-12 2021-11-16 /pmc/articles/PMC8594077/ /pubmed/34801920 http://dx.doi.org/10.1016/j.thromres.2021.11.008 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editors-in-Chief Zuin, Marco Cervellati, Carlo Rigatelli, Gianluca Zuliani, Giovanni Roncon, Loris Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
| title | Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
| title_full | Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
| title_fullStr | Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
| title_full_unstemmed | Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
| title_short | Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists? |
| title_sort | reduction of venous thromboembolic events in covid-19 patients: which role for il-6 antagonists? |
| topic | Letter to the Editors-in-Chief |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594077/ https://www.ncbi.nlm.nih.gov/pubmed/34801920 http://dx.doi.org/10.1016/j.thromres.2021.11.008 |
| work_keys_str_mv | AT zuinmarco reductionofvenousthromboemboliceventsincovid19patientswhichroleforil6antagonists AT cervellaticarlo reductionofvenousthromboemboliceventsincovid19patientswhichroleforil6antagonists AT rigatelligianluca reductionofvenousthromboemboliceventsincovid19patientswhichroleforil6antagonists AT zulianigiovanni reductionofvenousthromboemboliceventsincovid19patientswhichroleforil6antagonists AT ronconloris reductionofvenousthromboemboliceventsincovid19patientswhichroleforil6antagonists |